Edward Baker to Speak at Upcoming HCCA Annual Healthcare Enforcement Compliance Conference in Washington D.C.

Lieff Cabraser attorney Edward Baker will be a speaker at HCCA’s Annual Healthcare Enforcement Compliance Conference, taking place November 5-7, 2023 at the Capital Hilton in Washington D.C. On day two of the conference, Ed will co-lead a presentation on “FCA and Liability for Risk Adjustment,” where he will discuss the origins of liability for risk adjustment, the state of settlements and litigation, and recent final RADV rule and audit liability.

During this 3 day in-person program, attendees will have the opportunity to hear first-hand from government enforcement leaders about regulatory changes, expectations, and key priorities. They will also have the chance to gain insight into properly monitoring, detecting, investigating, and managing violations. Past speakers have included representatives from the HHS-OIG, Civil Division of the DOJ, U.S. Department of Health and Human Services, Office of Counsel to the Inspector General, and leaders in the healthcare enforcement compliance industry.

For more information regarding speakers, agenda, and registration, visit the event website.

About Edward Baker

Edward Baker is Of Counsel at Lieff Cabraser Heimann & Bernstein, LLP. He previously served as an Assistant U.S. Attorney in the Eastern District of California, where he was the Civil Healthcare Fraud Coordinator, as well as the Elder Justice Coordinator, within the Affirmative Civil Enforcement practice group. As an AUSA, Mr. Baker investigated numerous FCA cases, including allegations against physicians for medically unnecessary procedures, pharmacies for kickbacks to nursing homes, defense contractors and federal grant recipients for fraudulent billing, and hospitals for up-coding. He was the lead attorney for the United States in an FCA settlement against a group of Fresno cardiologists for performing medically unnecessary nuclear scans, and in a qui tam settlement against Omnicare, Inc., a national long-term care pharmacy, for improperly submitting claims for prescription drugs dispensed to patients in skilled nursing facilities. He worked closely with criminal prosecutors to enhance the district’s parallel proceedings practice and coordinated regular meetings of the EDCA Healthcare Fraud Task Force.

Prior to serving as an AUSA, Mr. Baker was an Assistant Attorney General for the State of Vermont, where he was the Director of the Medicaid Fraud and Residential Abuse Unit. He was a member of the litigation table team for thirty-six states in a qui tam lawsuit against Wyeth and Pfizer for Medicaid pharmaceutical “best price” violations that ultimately resulted in a $785 million settlement. He also laid the groundwork for the enactment of the Vermont False Claims Act and held leadership positions within the National Association of Medicaid Fraud Control Units.